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 I 
 
Abstract 
 
Antibiotic resistance is an emerging and serious threat to public health. Immediate 
actions are required to preserve current antibiotics while intensifying research efforts towards 
the development of new effective therapeutics. A novel approach to combat bacterial 
infections focuses on the inhibition of bacterial virulence to inhibit disease-causing properties 
rather than bacterial growth. In several Gram-positive bacteria, the bacterial enzyme sortase 
A (SrtA) is critical for an intact cell surface display of virulence-associated proteins. Inhibition 
of SrtA is, therefore, expected to greatly reduce bacterial virulence, serving as a potential 
therapeutic approach to treat Gram-positive infections. In order to fully exploit novel 
intervention strategies we need to further improve our understanding of bacterial virulence, 
persistence and stress responses.  
Firstly, this thesis describes the discovery, synthesis and evaluation of inhibitors of 
SrtA. Secondly, the phenotypic characterization of bacteria using Fourier-transform infrared 
(FTIR) spectroscopy as well as time-of-flight secondary ion mass spectrometry (ToF-SIMS) 
is discussed. 
A new class of SrtA inhibitors was identified by high-throughput screening of ~28500 
small-molecule compounds. Synthetic modification of hit structures yielded a series of 
compounds that exhibited increased inhibitory activity in a functional, FRET based, assay. 
Ligand-detected protein binding experiments using Carr-Purcell-Meiboom-Gill (CPMG) 
relaxation dispersion NMR spectroscopy confirmed binding to SrtA and guided the design of 
new structures. The reversibility of binding, binding kinetics, and binding affinity were 
determined by surface plasmon resonance (SPR) spectroscopy. All compounds tested 
displayed a reversible binding mode and some exhibited a very high binding affinity.  
In a feasibility study, FTIR spectroscopy in combination with design of experiment and 
multivariate statistical analysis (MVA) was applied to explore the condition dependent 
phenotypic diversity of Staphylococcus aureus. Planktonic cultures of S. aureus were grown under 
various conditions according to the experimental design. FTIR spectra obtained from each 
treatment group contained distinct profiles that allowed full cluster separation in principal 
components analysis (PCA).  
ToF-SIMS was employed for further and more detailed characterization of bacterial 
phenotypes by direct analysis of native cell samples. Initial experiments demonstrated the 
capability of ToF-SIMS, coupled with MVA, to fully differentiate Escherichia coli, Pseudomonas 
aeruginosa, as well as two strains of S. aureus. Further investigations focused more specifically 
on E. coli and explored the role of the stringent response in growth phase dependent lipid 
modifications. Mass spectral assignments revealed that a ppGpp0 mutant exhibited alterations 
in lipid composition in stationary phase. Results suggest the occurrence of alternative stress 
response mechanisms that are regulated independently of ppGpp. 
Keywords: Sortase A, SrtA, Inhibitors, Anti-virulence, Bacterial analysis, FTIR spectroscopy, 
Bacterial phenotyping, Design of Experiment, Multivariate Data Analysis, PCA, ToF-SIMS, 
Time-of-flight secondary-ion-mass-spectrometry, Lipid analysis, ppGpp, Stringent response.  
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1 INTRODUCTION 
 
 
1.1 The Global Threat of Antimicrobial Resistance 
The emergence of bacterial pathogens that are resistant to current antimicrobial 
therapies and the continuous spreading of their resistance genes constitute a serious threat to 
public health.1 With a shortage of effective therapeutic options, multidrug resistance presents 
one of our greatest challenges in combat against bacterial infections and associated diseases.2 
To avert a global health crisis, actions across all government sectors and society are urgently 
needed.3, 4  
 
Traditional approaches for the treatment and prevention of bacterial infections rely on 
the inhibition of bacterial growth by disrupting crucial bacterial processes such as cell wall 
synthesis, DNA replication, or protein synthesis.5 Antibiotics that inhibit growth by 
bacteriostatic (reversible inhibition of growth) or bactericidal (killing bacteria) actions exert a 
substantial evolutionary selection pressure which favors the selection for resistant 
subpopulations. Many of the antimicrobials available today are derived from natural 
compounds that originate from antibiotic-producing microorganisms. It is very likely that 
antibiotics and their resistance genes have evolved naturally for millions of years and existed 
long before their discovery.6, 7 The inappropriate and excessive human use of antibiotics, 
however, has unnaturally accelerated the evolutionary process contributing to the emergence 
of pathogens that are highly resistant to the majority of antibiotics currently available.2 
Furthermore, the mismanagement of antibiotics, particularly for non-curative purposes such 
as prophylaxis, metaphylaxis, and growth promotion in animal feed stocks has also 
exacerbated the global spread of resistance.2  
 
The World Health Organization (WHO) has recognized antimicrobial resistance as one 
of the greatest threats to public health, with a post-antibiotic era as a real possibility for the 
21st century.1 In the European Union, drug-resistant bacteria alone are estimated to cause 
25000 deaths with healthcare and socioeconomical costs amounting to EUR 1.5 billion each 
year.8 Similarly, the Centers for Disease Control and Prevention (CDC) estimates that in the 
USA more than 2 million infections and 23000 deaths annually are caused by antibiotic-
resistant bacteria.9 The current situation requires immediate actions at all societal levels to 
reduce the impact and spread of resistance. Synergistic actions of preserving the drugs at 
hand while intensifying research efforts towards the development of new therapeutics may be 
key to avert a global health crisis. In 2015, the WHO released a global action plan3 with the 
following strategic objectives that ‘aim to ensure that the prevention and treatment of infectious diseases 
with safe and effective medicines continues’: 
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 improving awareness of antimicrobial resistance 
 strengthening surveillance and research 
 reducing the incidence of infection 
 optimizing the use of antibiotics 
 ensuring sustainable investment in countering antimicrobial resistance 
 
The continuous increase in antibiotic resistant infections creates a strong need for novel 
effective therapies. The shortage of new antibiotics coming to market is associated with 
limited interests of pharmaceutical companies in the development of antimicrobial drugs. 
This lack of interest is the result of antibiotic management policies that limit the return of 
investment.2, 10 Companies may be stimulated to increase their efforts in the development new 
therapies by initiating policy changes, creating incentives, and lowering regulatory hurdles. 
 
Novel intervention strategies need to respond to current antimicrobial resistance and 
preferably circumvent selection pressure, which otherwise may again result in the onset of 
drug resistance.  
 
1.2 Bacterial Resistance, Tolerance, and Persistence  
Bacteria have evolved a number of strategies by which they can survive a number of 
environmental challenges, including antibiotic exposure. These survival strategies have been 
described and differentiated using the terms ‘resistance’, ‘tolerance’ and ‘persistence’ despite a 
certain ambiguity.11, 12 
1.2.1 Resistance 
Bacterial resistance to antibiotics is typically associated with inheritable resistance traits 
which involve molecular mechanisms that allow bacteria to continue to proliferate in the 
presence of high concentrations of antibiotics.12 These mechanisms are conferred by 
resistance genes and can be acquired and spread by horizontal gene transfer or developed by 
adaptive mutations. Resistance can arise due to (i) genetically mutated or post-translationally 
modified antibiotic targets, (ii) antibiotic efflux systems that reduce intracellular antibiotic 
concentration, or (iii) the ability to deactivate drug molecules by hydrolysis or structural 
modification.4, 12 In addition, the absence of a susceptible target or the inability of drugs to 
cross the cell envelope may confer intrinsic resistance.2, 6 
1.2.2 Tolerance 
Bacterial tolerance to antibiotics usually refers to the ability of the microorganisms to 
survive a transient exposure to normally lethal concentrations of bactericidal antibiotics.11, 12 
The mode of action of numerous antibiotics requires bacteria to be in an active metabolic 
state of growth. Tolerance to such antibiotics is associated with strongly reduced growth 
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rates.11 Various environmental conditions, including starvation stress, can induce phenotypic 
adaptations and metabolic adjustments that lead to slow growth or growth arrest.13-15 This 
can render phenotypic variants of an otherwise antibiotic-sensitive strain drug-tolerant. In 
contrast to resistance, tolerance is a transient phenomenon, which is not based on resistance 
genes. It also affects several classes of antibiotics rather than one specific class as found in 
bacterial resistance (except in cases involving multidrug resistance). 
1.2.3 Persistence 
Another bacterial survival strategy is based on the phenotypic heterogeneity of a 
bacterial population. Phenotypic heterogeneity is a phenomenon of evolutionary adaptation 
that promotes bacterial persistence under environmental insults.16 A clonal bacterial 
population exhibits a small fraction of persister cells (genetically identical phenotypic variant 
of typically less than 1%) that stochastically enter a state of slow growth, rendering them 
tolerant to antibiotics.17, 18 This subpopulation of persister cells is therapy-refractive and 
therefore presents a primary source for chronic and relapsing infections.19 Molecular 
mechanisms that lead to persistence and drug tolerance are often linked to the signaling 
molecule, ppGpp. Such mechanisms include toxin-antitoxin (TA) systems that reduce 
metabolic activity in response to stresses in fluctuating environments.20, 21 Persister formation 
may also be modulated by quorum sensing (QS), a bacterial communication phenomenon 
based on chemical signaling.22 The above mentioned systems are also associated with the 
formation of biofilms, multilayered bacterial communities, which may provide further 
protection against attacks from antibiotics and the host immune system.21  
 
1.3 Anti-Virulence Strategies to Combat Bacterial Infections 
As previously mentioned, the increasing threat of antimicrobial resistance demands the 
development of new therapeutics and alternative intervention strategies. An increasing 
amount of research effort has been devoted to strategies that are based on the inhibition of 
bacterial virulence.5, 23, 24 In this thesis, bacterial virulence refers to the quantitative capacity of 
a bacterium to infect and cause disease in host organisms.25 Bacterial virulence is dynamically 
regulated in response to environmental cues, such as conditions and signaling, and its extent 
may be dependent on a pathogen’s ability to multiply within the host.24, 26 Anti-virulence 
strategies focus on the interference with virulence associated mechanisms to confer 
inhibition to disease causing properties without killing the bacteria. As a consequence, this 
strategy might exert a milder evolutionary pressure for drug-resistant selection and lead to 
fewer undesirable effects to the host microbiota that are associated with traditional 
strategies.5, 24 Anti-virulence drugs may allow the host immune system to contain and clear 
the infection, and could alternatively be administered in a combination therapy with available 
antibiotics.5, 24 
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Numerous anti-virulence strategies are currently under investigation. These include 
targeting bacterial adhesion, invasion and biofilms, interfering with bacterial signaling and 
gene regulation systems, as well as inhibiting toxin function and specialized secretion systems. 
The following sections aim to highlight some of the major anti-virulence approaches that are 
being developed. 
1.3.1 Targeting Adhesion and Biofilms 
Bacterial adhesion to host cells is critical for the initiation of the infection process and 
to effectively colonize the host. Adhesion usually involves direct and specific interactions 
between bacterial surface proteins (adhesins) and receptors on the host cells.27 Most bacteria 
will only infect specific hosts and host tissues that present corresponding receptors.5 Gram-
negative bacteria most commonly exhibit adhesins incorporated in filamentous surface 
structures called pili or fimbriae, however, some bacteria express adhesins also in monomeric 
forms or complexes.24, 28, 29 Gram-positive bacteria feature Microbial Surface Components 
Recognizing Adhesive Matrix Molecules (MSCRAMMs) that are associated with virulence 
and biofilm formation.30, 31 Attachment to host cells enables bacteria to avoid mechanical 
removal or clearance by the host immune system and further promotes the formation of 
biofilms.27 Moreover, contact is required for the activation of specific toxin secretion systems 
and for toxins that depend on certain local toxin concentrations in order to be effectively 
active.32  
 
Anti-virulence strategies that aim to inhibit bacterial adhesion may limit the interaction 
between bacteria and host cell early on in the infection process and in turn, reduce the risk 
for the establishment of infections.24, 33 Decreased surface adhesion and biofilm formation 
would render bacteria less protected against antibiotic exposure and clearance by 
phagocytosis.34 Furthermore, it may prevent the activation of toxin secretion systems and the 
release of host cell damaging factors.32 Ideally, inhibition of adhesion would not affect in vitro 
growth and thus, exert only a low pressure for drug resistant selection. Therefore, inhibition 
of adhesion and biofilm formation may be an effective strategy to prevent and combat 
bacterial infections.  
 
Anti-adhesion strategies may include direct inhibition of adhesins, their presentation on 
the cell surface, or assembly of bacterial surface structures that effect adhesion. For example, 
bicyclic 2-pyridones were discovered to inhibit the formation of pili in uropathogenic 
Escherichia coli. As a result of reduced pilus formation, these ‘pilicides’ effected significantly 
reduced bacterial adherence to bladder cells, and biofilm formation.35 Gram-positive bacteria, 
such as Staphylococcus aureus, use sortase enzymes to attach proteins and assemblies (including 
adhesins and pili) to the cell wall for surface display.33 Specifically, sortase A (SrtA) was 
found to be essential for bacterial virulence and therefore presents a potential anti-virulence 
target to prevent adhesion and biofilm formation (SrtA is further discussed in Section 3.1). 
Further strategies that specifically target biofilms may prevent their formation or lead to their 
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resolution.5 Quorum sensing plays an important role in the control of biofilm formation and 
virulence.36 Therefore, it serves as a valuable target for anti-virulence therapy, which is 
discussed further in the following section.  
1.3.2 Targeting Signaling and Regulation 
Bacteria carefully control the expression of their virulence factors in efforts to optimize 
energy expenditure.5 Virulence gene expression is regulated at various levels and implicates 
complex regulatory networks. Thereby, numerous mechanisms are involved, which often rely 
on sensing environmental signals.24 These signals can arise from conditions, such as nutrient 
availability, or from other bacteria that use chemical signaling for quorum sensing (QS).5 
Various nutritional stress cues may trigger the stringent response (i.e. a global stress 
response), which is, among other things, implicated in the regulation of virulence. The 
stringent response is discussed in detail in Section 5.3.1. In QS, bacteria release QS signaling 
molecules into their surrounding environment, which accumulate upon bacterial population 
growth. QS systems allow bacteria to sense cell density in order to respond with appropriate 
adjustments in gene expression that effect regulation of bacterial virulence traits.37 For 
example, Pseudomonas aeruginosa uses two groups of chemical signals, acyl homoserine lactones 
(AHLs) and the 4-quinolones, also referred to as Pseudomonas quinolone signal.5 These are 
involved in several quorum-sensing mechanisms that regulate the expression of an array of 
virulence traits including adhesins, proteases, toxin secretion systems and the formation of 
biofilms.24, 38 The Gram-positive bacterium S. aureus regulates its virulence gene expression 
via the two-component Agr QS system, involving autoinducing peptides (AIPs) that function 
as QS signaling molecules. These AIPs bind to histidine sensor kinase (AgrC) in the bacterial 
membrane, which as a result, activates a response regulator (AgrA). The response regulator, 
AgrA, is usually a transcription factor responsible for the stimulation of gene transcription, 
which finally leads to the expression of virulence factors.24  
 
Due to its pivotal role in the expression of virulence traits, QS is the focus of many 
anti-virulence strategies that attempt to exploit signaling pathways as therapeutic targets.39 
Strategies that target QS may interfere in various mechanisms in underlying pathways for 
example, inhibition of signal synthesis, inhibition of signal binding to AgrC, or degradation of 
signal molecules (quorum quenching).29 QS systems are not usually found in eukaryotic host 
cells and in summary makes QS an attractive target for pharmacological intervention.5  
 
Interfering with QS may reduce bacterial virulence with therapeutic effect. QS mutants 
of various types of bacteria were found to exhibit reduced virulence in vivo.5 Further, a small 
molecule inhibitor of QS, C-30, was found to be efficacious in a mouse pulmonary infection 
model against P. aeruginosa as a result of inhibited virulence factor expression.40 An example 
of interference with the Agr system of S. aureus presents Solonamide B, a natural compound 
isolated from marine microorganisms. Solonamide B interfered competitively with AIP 
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binding to the AgrC receptor, which led to strong reduction in virulence as a result of 
decreased toxin activity (𝛼-hemolysin, phenol-soluble modulins).41, 42 
1.3.3 Targeting Toxins and Secretion Systems 
Numerous bacterial species exhibit toxins and sophisticated secretion systems with 
which they fight competitors and acquire nutrients with various, but mostly damaging, effects 
to their host.43-45 Tissue damage and cellular malfunctions are caused by exotoxins and 
effectors, and give rise to serious disease symptoms of, for example, anthrax disease.46 
Exotoxins are virulence factors that are excreted into the extracellular environment where 
they can directly act on host cells and inhibit cellular functions. Most exotoxins are pore-
forming proteins, capable of oligomerizing and inserting into the membrane of the host cell 
to form a transmembrane pore, which potentially leads to cell death.47 Effectors, on the other 
hand, are proteins that are injected into the host cell cytoplasm via specialized secretion 
systems. There, they modulate host cell functions by interfering in signaling pathways to 
promote the disease process.5 There are three types of secretion systems (type III, IV, and 
VI) that are known to mediate the translocation of bacterial effectors.5 The type III secretion 
system (T3SS) is a multi-protein assembly with a needle-like structure that crosses the 
bacterial cell envelope.24, 48 The T3SS is conserved between different bacteria and has shown 
to be essential for the virulence of many Gram-negative pathogens such as P. aeruginosa, E. 
coli, Salmonella spp., Shigella spp., and Chlamydia spp.29, 39, 48  
 
Toxins and effectors are maybe the most obvious mediators of bacterial virulence and 
thus, are the focal point of multiple anti-virulence strategies. These strategies target the 
synthesis, the activity, and trafficking pathways of exotoxins by competitive inhibition or 
neutralizing antibodies.5, 49 Furthermore, inhibition of effector translocation by interfering 
with secretion systems (such as T3SS) may prevent damage to the host and the progression 
of the disease.48  
 
Aurodox, a linear polyketide compound, was found to selectively inhibit T3SS-mediated 
hemolysis and effector secretion (EspB, EspF and Map) without affecting bacterial growth in 
vitro. In vivo studies demonstrated that the use of aurodox contributed to the survival of mice 
infected with Citrobacter rodentium, which was used as model strain for human pathogens, such 
as enteropathogenic E. coli (EPEC).50 An example for an anti-virulence strategy targeting 
exotoxin synthesis is given by the small-molecule compound virstatin. By interfering with the 
homodimerization of the transcription factor, ToxT, in Vibrio cholera, virstatin prevents the 
expression of cholera toxin and the toxin co-regulated pilus. As a result, virstatin protected 
mice from intestinal colonization by V. cholerae.51 Unfortunately, bacterial resistance to 
virstatin, arising from a single nucleotide polymorphism in ToxT, has already been 
observed.51 
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1.3.4 Potential and Limitations  
Research directed towards anti-virulence therapies has produced promising evidence 
suggesting that the inhibition of virulence may prove to be an effective strategy to prevent 
and combat bacterial infections.5, 24, 29, 39 Anti-virulence therapy may enable the normal host 
immune response to contain and clear the infection, and may also be coupled with the use of 
commercially available antibiotics.5 This approach may have synergistic therapeutic effects 
and extend the effective life-span of a drug (from initial use in the clinic to the onset of 
resistance). The development of successful anti-virulence strategies is challenged by a 
redundancy of mechanisms and pathways underlying virulence expression. Optimally, the 
targeted virulence mechanisms are fundamental, conserved and present in multiple pathogens 
allowing for a broad-spectrum therapy.24 Strategies that target pathogen specific mechanisms 
might only allow narrow-spectrum therapies. For those to be effectively applicable, rapid and 
accurate diagnostics are required in order to identify the involved pathogen(s). These 
diagnostics may include extended pathogen profiling (e.g. genotyping, identification of 
virulence factors) and may also help to improve the overall use of antibiotics in general.29, 52 
 
Another challenge in the development of an anti-virulence drug may be to convince 
large pharmaceutical companies that have little interest in antimicrobial drug development, to 
support late-stage drug development of, for example, academic projects. The early stages of 
drug development programs are often the strength of academia and small biotechnology 
companies. However, the later stages largely require increased financial efforts and often 
demand the capacity of a large pharmaceutical company.29 
 
Decreased susceptibility towards the development of antibiotic resistance and fewer 
undesirable effects to the host micro flora (as compared to traditional antibiotics) are 
considered to be the major advantages for pursuing the development of anti-virulence 
drugs.5, 24 However, even if the direct selection pressure is minimized, it is unlikely that 
resistance against anti-virulence drugs will not develop over time. It has been demonstrated 
that oxidative stress (H2O2) selects for strains with active QS systems, e.g. mutants that are 
resistant to QS inhibitors.53 Further, it can be speculated that the host immune system, which 
is expected to clear the infection, might exert a selection pressure itself. This might lead to 
the development of resistance by enhanced immune evasion (e.g. as in biofilms) or by 
defense mechanisms that attack cells of the immune system (e.g. as Panton-Valentine 
leukocidin54). Applying antibiotics and anti-virulence drugs in combinational therapies may 
allow to delay the emergence and spreading of such adapted pathogens.29 Finally, to fully 
exploit anti-virulence strategies, continued research is required to improve our understanding 
of virulence mechanisms and potential consequences of interfering with them in the context 
of anti-infective therapies.5  
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2 AIMS OF THE THESIS 
 
 
The overall aim of the work presented in this thesis was the discovery of novel Sortase A 
inhibitors and the characterization of bacterial phenotypes. 
 
 
The specific objectives of the thesis were: 
 
 Discovery and development of Sortase A inhibitors by high-throughput screening and 
improvement of biophysical properties by synthetic efforts (Paper I) 
 
 Exploring the feasibility of characterizing growth condition dependent phenotypic 
diversity of Staphylococcus aureus with vibrational spectroscopy (Paper II) 
 
 Exploring the potential of time-of-flight secondary ion mass spectrometry in 
conjunction with multivariate data analysis for bacterial analysis (Paper III) 
 
 Investigating the role of the stringent response in growth phase dependent lipid 
modifications in Escherichia coli (Paper IV) 
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3 DISCOVERY AND DEVELOPMENT OF SORTASE A 
INHIBITORS (PAPER I) 
 
 
The bacterial enzyme Sortase A (SrtA) has previously been identified a potential anti-
virulence target. The following chapter describes the discovery and early development of 
inhibitors against S. aureus SrtA.  
 
3.1 Sortase A 
3.1.1 Biological function 
The Sortase A (SrtA) enzyme is a membrane bound cysteine transpeptidase that plays a 
key role in the attachment of surface proteins to the cell wall in a number of Gram-positive 
bacteria.55-57 These surface proteins include cell wall anchored virulence factors, such as 
protein A, fibronectin-binding proteins, and clumping factors which belong to the 
MSCRAMMs.30, 56, 57 MSCRAMMs enable bacterial adhesion to host cells, promote infection, 
provide protection from the immune system, and are implicated in biofilm formation.30 SrtA 
substrates are expressed as precursor proteins with a C-terminal sorting signal, consisting of a 
positively charged tail, a hydrophobic domain and an LPXTG motif.56, 58 The active site of 
SrtA — represented by the widely conserved catalytic triad His120, Cys184, and Arg197 — 
recognizes the LPXTG motif of the precursor proteins. The mechanism of surface protein 
anchoring by SrtA is illustrated in Figure 1. The sulfhydryl group of Cys184 undergoes 
nucleophilic attack on the carbonyl carbon of Thr in the LPXTG motif, resulting in the 
cleavage of the amide bond between Thr and Gly and in turn, the formation of a thioacyl-  
 
 
 
Figure 1. Illustration of the mechanism by which SrtA mediates the attachment of surface 
proteins to the bacterial cell wall.57 Reprinted by permission from Macmillan Publishers 
Ltd: Nature Reviews Microbiology 9: 166-176, copyright (2011). 
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enzyme intermediate. Lipid II* is a cell wall precursor molecule that is essential for bacterial 
cell-wall biosynthesis.59 The terminal amino group of the pentaglycine moiety of Lipid II 
attacks the carbonyl carbon of Thr within the thioacyl-enzyme intermediate. The resulting 
product, a protein-lipid-II precursor, is released which concludes the catalytic cycle of the 
SrtA transpeptidation reaction. The protein-lipid II precursor is then incorporated into the 
cell wall during cell wall synthesis via transglycosylation and transpeptidation.57, 60 
3.1.2 Sortase A as drug target 
SrtA is essential for the virulence of a number of clinically relevant pathogens, such as 
methicillin-resistant S. aureus (MRSA), and has, therefore, been recognized as a potential drug 
target. Gene deletion studies demonstrated the critical role SrtA plays in surface display for 
bacterial virulence, infection potential, and biofilm formation.33, 61, 62 For example, srtA 
mutant S. aureus was incapable of causing renal abscesses and acute infection in mice, and 
displayed a significant reduction in mortality rates.56, 63 Also, srtA mutants were more 
susceptible to macrophage-mediated killing.64 Reduction of virulence and pathogenesis in 
animal infection models has also been reported for srtA mutants of other Gram-positive 
pathogens, such as Listeria monocytogenes,65, 66 Streptococcus pneumoniae67 and Streptococcus suis.68 
When compared to other genes of the sortase family, deletion of the srtA gene has been 
shown to have the most significant effect on pathogenesis reduction and virulence.63 
Recently, the proof of concept for the efficacy of small-molecule SrtA inhibitors as anti-
infective drugs has been demonstrated.69, 70 Importantly, srtA mutants are viable in rich 
medium, suggesting that SrtA is not required for bacterial growth which potentially reduces 
the selection pressure for resistance development.33, 56, 63 The extramembranous location of 
the SrtA active site may be highly beneficial in facilitating the engagement of the drug, thus 
eliminating potential challenges that may arise due to issues associated with permeability and 
efflux pumps. SrtA homologs have not been identified in eukaryotic host cells and may, 
therefore, provide selective binding of SrtA inhibitors.62 In addition, the conservation and the 
widespread use of SrtA by various pathogens may allow for the realization of a broader 
spectrum of drugs. In conclusion, SrtA is a promising target for therapeutic intervention by 
anti-virulence drugs.  
3.1.3 Sortase A inhibitors 
A number of compounds with SrtA inhibitory activity have been discovered by 
screening natural products or small molecule libraries, via computational strategies or rational 
drug design.62, 71 A series of natural product inhibitors of SrtA is shown in Figure 2. One of 
the first natural products to be described as a SrtA inhibitor was β-sitosterol-3-O-
glucopyranoside 1, which was extracted from Chinese medicine plants.72 Berberine chloride 2 
was extracted from rhizomes of Coptis chinensis and shows slight inhibition of S. aureus growth 
(MIC 100 mg/L).73 The SrtA inhibitors, bis(indole) alkaloid 3 and isoaaptamine 4, were 
                                              
*undecaprenyl-pyrophosphate-MurNAc(-L-Ala-D-iGln-L-Lys(NH2-Gly5)-D-Ala-D-Ala)-β1-4-GlcNAc 
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isolated from marine and tropical sponges, respectively.74, 75 Additional SrtA inhibitors 
isolated from plant extracts include curcumin 5,76 rosmarinic acid 8,77 and chlorogenic acid 
7.69 Chlorogenic acid 7 shows no significant growth inhibitory activity against S. aureus and 
was found to protect mice from S. aureus-mediated renal abscess with significantly decreased 
mortality.69 Also, a number of naturally occurring flavonoids such as morin 8,78 quercitrin,79 
kurarinol,80 and flavonoid glycosides81 have been found to inhibit SrtA activity and biofilms. 
Wallock-Richards et al. rationally reduced the structural complexity of flavonoids to a 
common trans-chalcone 9 scaffold. They demonstrated that trans-chalcone 9 inhibited SrtA 
and Streptococcus mutans biofilm formation in vitro by irreversible binding to SrtA Cys184.82 
Further, dihydro-β-carboline 10 is a SrtA inhibitor derived from marine sponge natural 
products with no inhibitory effect on bacterial growth.83 
 
 
Figure 2. Natural product inhibitors of SrtA.  
 
Additional SrtA inhibitors were found by high-throughput screening (HTS) or in silico 
screening efforts from small-molecule libraries and are shown in Figure 3. The 
diarylacrylonitrile 11 proved to be the most active compound in an optimization series of a 
lead compound discovered by HTS. Diarylacrylonitrile 11 displayed reversible binding to 
SrtA and decreased renal infections in mice models infected with S. aureus Newman. While 
mortality rates were reduced, compound 11 exhibited undesirable toxic side effects.84 Aryl(β-
amino)ethyl ketone (AAEK) 12 displays irreversible inhibition of SrtA through the formation 
of covalent bonds to the Cys184 within the active site.85 Suree et al. discovered rhodanine 13, 
pyridazinone 14, and pyrazolethione 15 as novel SrtA inhibitors resulting from optimization 
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of HTS hits.86 Zhulenkovs and co-workers reported a series of benzisothiazolinone-based 
SrtA inhibitors such as compound 16 that displayed IC50 values ranging from 3.8–12.8 µM. 
Most of the benzisothiazolinones inhibited NIH 3T3 mice fibroblast cells (IC50 1.3–263 µM) 
and bacterial growth in vitro.87 Rebollo et al. recently described a macrocyclic peptide that 
inhibits SrtA reversibly with an IC50 value of 167 μM.88 More recently, phenylhydrazinylidene 
derivatives (such as compound 17) have been reported as modest SrtA inhibitors that 
inhibited biofilm formation but not bacterial growth in vitro.89 Zhang et al. discovered the 3,6-
disubstituted triazolothiadiazole 18 through in silico screening and subsequent optimization. 
Compound 18 was found to inhibit SrtA without affecting bacterial growth and protected 
mice from lethal S. aureus bacteremia.70 Several of the shown SrtA inhibitors may result in 
covalent modification of the active site, despite some being reversible binders. 
 
 
Figure 3. Inhibitors of SrtA discovered by screening of small-molecule libraries.  
 
Recent advances in this field have seen the development of SrtA inhibitors with IC50 
values in the low micromolar range. However, despite these recent efforts, many of the SrtA 
inhibitors have insufficient potency, undesirable structural features, selectivity issues, and 
require further optimization in order to be therapeutically useful.  
 
3.2 Biophysical Evaluation Methods 
3.2.1 FRET based functional SrtA assay 
Functional assays, based on fluorescence resonance energy transfer (FRET), have 
previously been successfully applied to screen for SrtA inhibitors.71 FRET is a non-radiative 
energy-transfer process that occurs between a donor and an acceptor molecule in close 
proximity (typically distance r < 10 nm).90 The energy is transferred through long-range 
dipole–dipole interactions and is thus highly distance-dependent (inversely proportional to 
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r6).91 Furthermore, FRET depends on the overlap of the absorption and emission spectra of 
the acceptor and the donor, respectively, and on their transition dipole orientations. This 
distance-sensitivity of FRET can be exploited to investigate molecular interactions.  
3.2.2 NMR (CPMG) protein binding assay 
One-dimensional 1H Carr-Purcell-Meiboom-Gill (CPMG) relaxation dispersion NMR 
experiments were performed for ligand-detected protein binding.92 The CPMG relaxation 
dispersion exploits the differential T2 relaxation properties of a ligand in free or protein-
bound state to indicate protein binding. When a ligand binds to a protein, its rotational 
correlation time assumes that of the protein (increases). This leads to shorter relaxation times 
and results thereby in line-broadening. In a CPMG relaxation dispersion experiment a series 
spin-echo pulse elements are applied to refocus the spreading spins (T2 relaxation) precessing 
in the transverse plane. The spin-echo element (τ-180x,y-τ) contains a 180° radio-frequency 
pulse and two relaxation delays τ (~0.25-25 ms). The spins can be refocused if their average 
chemical shift during the two τ periods are identical. However, if the chemical shifts during 
the τ periods are different, for example when a ligand translates from free and protein-bound 
state, the spins do not return symmetrically and will, therefore, not refocus. NMR spectra of 
the ligand are recorded in both the absence and presence of the protein (usually, with a 
ligand-to-protein ratio of 10:1). A binding interaction will result in a decrease in signal 
intensity, provided the exchange between the free and bound state is in the intermediate-fast 
regime. Ligand binding to the protein can be detected over the μM-mM affinity range. 
Ligands with high affinity have low dissociation rates, and exchange therefore slowly. This 
may result in false negatives as the signal decreases only slightly (depending on the ligand-to-
protein ratio). The reversibility of binding can be assessed through competitive binding 
experiments, whereby a known binder is added. Subsequent recovery of the signal may 
indicate reversible binding.93, 94 
3.2.3 Surface plasmon resonance (SPR) spectroscopy 
SPR spectroscopy was used for studying ligand-SrtA binding interactions to quantitate 
binding affinities and kinetics. SrtA protein is immobilized onto a sensor chip surface 
(functionalized gold film on glass support) within a flow cell. Ligand molecules in solution 
are passed over the chip surface allowing the ligand to interact with the bound SrtA. Binding 
interactions with ligand molecules change the refractive index of the medium in near the chip 
surface which can be monitored in real time. This allows to accurately measure the binding 
affinity through association and dissociation kinetics of the interaction. 
SPR spectroscopy exploits the phenomenon of surface plasmon generation. Polarized 
light is directed through a prism, reflects off the backside of the gold film and subsequently 
passes into a detector. At a certain incidence angle (resonance angle), the light is absorbed by 
the electrons in the gold film causing them to resonate (surface plasmons). This absorption 
leads to a decrease in intensity of the reflected light and gives rise to minimum in the SPR 
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reflection intensity curve. The SPR angle is dependent on the refractive index of the medium 
close to the gold surface and changes, for example, during binding interactions.95, 96 
 
 
3.3 Discovery and Development of Sortase A inhibitors (Paper I) 
[Unpublished data has been removed in this e-publication.] 
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4 TOWARDS A GLOBAL ESTIMATE OF BACTERIAL 
PHENOTYPIC DIVERSITY (PAPER II) 
 
 
As a result of adaptation to the environment, bacteria display phenotypes with variable 
virulence properties and susceptibilities to antimicrobials. A global estimate of bacterial 
phenotypic diversity based on principal components analysis (PCA) and Fourier transform 
infrared (FTIR) fingerprinting may allow for the identification of a subset of growth 
conditions under which newly developed antimicrobials could be evaluated for their efficacy 
against different phenotypes. In the following chapter, the feasibility of utilizing FTIR 
spectroscopy for the characterization of bacterial phenotypic diversity of S. aureus grown 
under variable sets of environmental conditions was explored.   
 
4.1 FTIR Spectroscopy as Tool for Rapid Bacterial Phenotyping 
Vibrational spectroscopy techniques have previously been successfully applied for the 
characterization, discrimination and identification of microorganisms.97 In particular, 
transmission FTIR spectroscopy was found to be capable of bacterial discrimination on 
strain and sub-strain level.98, 99 Additionally, Fourier transform infrared spectroscopy-
attenuated total reflectance (FTIR-ATR) of fatty acid methyl esters (FAMEs) has been 
successfully employed to distinguish bacteria on a phenotypic level.100 In contrast to analysis 
methods that investigate a small sub-set of the sample chemistry, FTIR spectroscopy 
provides insight into the total composition of bacterial cells. FTIR spectra can be measured 
on intact bacterial cells with minimal sample preparation. As a result, the spectra are 
composed of the superposition of contributions from the cells’ biomolecules. Interpretation 
of the spectra can be guided by five spectral regions that are important for bacterial 
characterization (Figure 4 and Table 1). In conclusion, FTIR spectroscopy offers quick and 
sensitive analysis with, however, limited structural information of the sample chemistry.  
 
 
Figure 4. Spectral regions in the FTIR spectrum of S. aureus relevant for bacterial 
characterization. Annotations are listed in Table 1.101 
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Table 1. IR regions with characteristic information for bacterial analysis, as illustrated in 
Figure 4.101 
No. Information 
Spectral region 
[cm-1] 
I Fatty acids CH-stretching 3000-2800 
II Amide I and amide II bands of proteins and peptides 1700-1500 
III Fatty acids, proteins, phosphates containing species 1500-1200 
IV Polysaccharides CO-stretching 1200-900 
V Unique bacteria specific absorbances  900-700 
 
4.2 Design of Experiments 
Design of Experiments (DoE) is an efficient procedure for the strategic planning of 
experiments involving multiple variables (factors). It aims to maximize the information 
gained from a minimal number of experiments by simultaneously changing variables and 
observing the resulting effects on the responses. Thereby, defining relevant experimental 
factors at meaningful levels and appropriate responses is critical for the informative value of 
the resulting data. Mathematical models are used to describe the relationships between 
factors and responses, as well as interactions between the factors (synergy, antagonism). A 
full factorial design comprises experiments of all combinations of k factors at two levels. This 
results in 2k experiments that are usually supplemented with a triplicate center point to 
recognize non-linear relationships and to determine confidence intervals. Such designs are 
balanced and orthogonal, which allows for the generation of unbiased estimates. The models 
allow for the recognition of optimal factors settings and can therefore be used in the 
optimization and the testing of robustness of methods and products. Experimental design is 
an efficient way to systematically examine multi-factor systems in order to obtain valid and 
objective conclusions.102 
 
4.3 Multivariate Data Analysis (MVA) 
4.3.1 Principal components analysis 
Principal components analysis (PCA) is a powerful statistical technique for extracting 
meaningful information from data with multiple variables. PCA is a mathematical procedure 
that reduces the dimensionality of complex multivariate data while retaining most of the 
variation within the data set. Dimensionality reduction is achieved by identifying directions 
with the largest variation in a data set, the so called principal components (PCs). The first 
principal component is the direction with the largest variation in the data set. Further 
components are directions with the largest variation that are orthogonal to previous 
components. Each observation obtains a score value for each component, which are co-
ordinate values for the new projection. The data is then represented using scores plots, which 
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allows for the appreciation of an entire set of data with fewer dimensions. The data can then 
be visually examined to interpret the data structure and to identify patterns and relationships. 
The information on how the variables contribute to the scores may be drawn from by the 
PCs’ loadings. The quality of input data is critical as PCA only changes their projection for 
enhanced interpretability. Variation caused by systematic experimental artifacts may result in 
dominant PCs. Therefore, knowledge of the experimental procedure and understanding of 
the methods used to create the data is of advantage for drawing appropriate conclusions.   
 
Data preprocessing 
Data often have to be pretreated in order to obtain a useful PCA model. This usually 
includes mean-centering and scaling the data set. Additional preprocessing procedures 
include transformations, corrections and compressions. Mean-centering subtracts the average 
of each variable from the data, both simplifying the PCA algorithm and improving the 
interpretability of the model as a result.103 In this work, all data were mean-centered prior to 
PCA, either without or in combination with scaling methods. Since PCA weights are based 
on variation, large variables having large variances would have a higher contribution in the 
PCA model. Therefore, scaling can be used to normalize the often large numerical ranges and 
thereby largely different variances of variables. Unit variance (UV) scaling is the most 
commonly used scaling method. In UV scaling, the data are divided by the standard deviation 
of each variable. As a result, all variables obtain an equal chance of influencing the model. 
Alternatively, Pareto scaling divides each variable by the square root of the standard 
deviation, representing an intermediate scaling method between unit variance scaling and no 
scaling.  
Further preprocessing methods can be applied to e.g. FTIR spectral data to remove 
physical effects that are caused by light scattering, random noise, small film thickness 
variations, and baseline drifts. Methods used for spectral preprocessing include 
normalization, orthogonal signal correction (OSC), standard normal variate (SNV) 
transformation, multiplicative scatter correction (MSC), Savitzky–Golay (SG) smoothing and 
the application of derivatives.15, 99, 100, 104, 105 In MSC, each observation is normalized by 
regressing it against the average spectrum. Data treated with SNV transformation are 
normalized by subtracting the mean and dividing by the standard deviation. The application 
of derivatives may be useful for normalizing baseline offset. SG smoothing is often applied in 
combination with derivatives in efforts to mitigate adverse effects of derivatives on noise. 
The degree of SG smoothing is adjusted by varying the range of the moving average.103 
 
Cross validation 
Cross validation (CV) is a model validation technique used to assess the predictive 
ability of a model. During CV, the data set is divided randomly into equally sized parts (e.g. 
seven equal blocks). Each part is then once excluded from the model building and used as a 
test set. The values predicted for the test sets are finally compared with their actual values to 
then calculate the predictability value Q2. CV is a useful measure to estimate the numbers of 
significant principal components and to limit problems like overfitting.106 
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4.3.2 Orthogonal Partial Least Squares projections to latent structures (OPLS) 
OPLS is another multivariate statistical method based on dimensionality reduction. In 
contrast to PCA, which identifies maximum variance in a data set (X-matrix), the OPLS 
discriminant analysis algorithm maximizes the separation of classes and is based on linear 
regression. The OPLS projection is guided by supplied class information (Y-variables) and is, 
therefore, a supervised method, whereas PCA is unsupervised. The variability in the X-matrix 
is divided into systemic and residual variability. The systemic variability is further divided into 
a predictive part that is correlated to Y and an orthogonal part that is uncorrelated to Y. The 
objectives are to identify which X-variables in the data set drive class separation.107  
4.3.3 Multiple linear regression 
Multiple linear regression (MLR) is a statistical technique for modelling linear 
relationships between independent explanatory variables and a dependent response variable. 
It is therefore well suited for analyzing the relationship between the orthogonal factors of a 
factorial design. Linear curve fitting is achieved by minimizing the sum of squared deviations. 
Thereby, the independent variables are fit separately. MLR aims to predict the degree of 
influence the independent factors have on the response variable. 
 
4.4 Investigation of Bacterial Phenotypic Diversity (Paper II) 
In order to determine whether the phenotypic diversity of S. aureus could be 
characterized using FTIR spectroscopy, appropriate methods needed to be developed. Initial 
efforts included the establishment of a suitable instrumental setup and protocol for efficient 
sample preparation so that reproducible results could be realized. Cultures of S. aureus were 
then grown in various conditions according to an experimental design and the spectral data 
obtained from their FTIR analysis were investigated by PCA. 
4.4.1 Selection of the instrumental setup 
Transmission FTIR spectroscopy was selected for the analyses of this study after 
comparison to FTIR-ATR spectroscopy and Raman spectroscopy. The apparent advantages 
of transmission FTIR spectroscopy included its high sensitivity (required for the analysis of 
biofilms) reproducibility, and the potential for rapid throughput. A quick sample throughput 
was realized by acquisition settings and the implementation of a custom made xy-stage 
(Appendix 8.4). A comparison of optical substrates including zinc selenide (ZnSe), silicon 
waver, and polyethylene resulted in the selection of ZnSe due to reproducible quality of the 
optical windows. The optical quality was further improved by the application of a 
monocrystalline ZnSe well plate (Appendix 8.5). Reproducibility of the combined instrumental 
setup, including the FTIR instrument, xy-stage, and ZnSe well plate, was validated by close 
clustering of spectra from repeated recordings on PCA scores plots (Figure 6).  
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4.4.2 Development of bacterial sample preparation 
In order to preserve the authenticity of bacterial samples, sample preparation was kept 
to a minimum by simple washings of the cells. As a consequence, the bacteria remained 
viable. As such, the time-span from harvesting to analysis was kept short to prevent the 
occurrence of metabolic changes when removed from treatment conditions.14 Harvested cells 
were washed three times with pure water to remove confounding contributions from growth 
medium. The various cultivation conditions led to differential growth rates and resulted thus 
in unequal cell densities of cultures (OD590nm 0.44–1.22). By taking into consideration the 
various optical densities, sample concentrations could be adjusted to achieve equivalent 
biofilm thicknesses when applied onto the ZnSe well plate. Potential small film thickness 
variations could be treated by spectral filters. The even application of samples was crucial for 
the reproducibility of results. Due to the low wettability properties of ZnSe, aqueous samples 
are challenging to apply evenly. A small amount of detergent (0.0005% Tween20) in the 
sample dilution was included to allow for an even application. Further, applying small sample 
volumes (5 µL) kept drying durations (20 min, 40 °C) and sample preparation time to a 
minimum.   
4.4.3 Experimental design of cultivation conditions 
Factors chosen for the full factorial design were pH, temperature and salinity with 
ranges selected to include potential variation in conditions observed in wound sites.108 A 
graphical illustration of the experimental design is shown in Figure 5 with treatment 
conditions listed in Table 2. Implementation of this design aimed primarily on an even and 
well balanced sampling of conditions for analysis by PCA, rather than the commonly used 
MLR evaluation of factors.  
 
Figure 5. Schematic representation of the experimental design with limit conditions for 
environmental factors (red) under which cultures of S. aureus were grown. Additionally, 
the standard cultivation condition (blue) and the center-point condition (orange) were 
included. The numbering corresponds to treatment groups in Table 2 and Figure 7. 
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Table 2. Treatment groups and their combinations of cultivation conditions used in the 
full factorial design.  
Treatment 
Group 
NaCl conc 
[% w/w] 
pH Value Temperature 
[°C] 
1 0 6 35 
2 5 6 35 
3 0 8 35 
4 5 8 35 
5 0 6 39 
6 5 6 39 
7 0 8 39 
8 5 8 39 
9 2.5 7 37 
10 2.5 7 37 
11 2.5 7 37 
12 0 7 37 
 
 
4.4.4 Preparation of FTIR spectral data for MVA  
FTIR spectra were obtained from all cultures grown according to the experimental 
design (Figure 6A). The raw spectra were visually inspected to carefully select spectral regions 
for PCA. IR regions with small within-group variation, as highlighted in Figure 6A, did not 
appear to contain information important for group differentiation. Some of these variations 
are likely to arise from water contributions (absorbing at 4000 to 3300 cm−1 and 2200 to 
1200 cm−1)105, however, no correlations to the order of sample preparation were identified. 
SNV transformation emphasized the strong similarity between the spectra of the different 
groups, as shown in Figure 6B. There, regions with observed differences between spectra of 
the treatment groups are highlighted. Several of those have been reported to be useful for 
bacterial characterization109 and the discrimination of a mutation induced SCV phenotype.98 
Savitzky-Golay (SG) smoothing of spectral noise reduced small variations and was done to 
avoid the unfavorable effect of noise during first derivation.98 A SG-smoothing average over 
45 points appeared optimal, regarding PCA clustering, for data recorded with a resolution of 
4 cm-1 and 8 averaged scans (Figure 6C). The data were UV scaled (and centered) as a last 
step of data pretreatment prior to PCA. As differences between the treatment groups were 
expected to be small, it appeared appropriate to scale all absorbance values to unit variance. 
The combined preprocessing methods included following steps:  
 
1. SNV transformation  
2. SG-smoothing (quadratic order, 45 points of smoothing) 
3. First derivative (quadratic order, 15 points of smoothing) 
4. Restriction of spectral regions (3600-2450 cm−1 and 2200-700 cm−1) 
5. UV scaling, centering 
factorial limit conditions 
standard cultivation condition 
center point (n = 3) 
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Figure 6. Preprocessing of FTIR spectra obtained from all bacterial treatment groups. A) 
raw spectra, regions of within-group variations are marked (4000–3600 cm−1, 2450–
2200 cm−1, <700 cm−1), the spectral region 2450 to 2200 cm−1 may include variations in 
characteristic signals from CO2; B) spectra after SNV transformation, spectral differences 
between treatment groups are marked (2970-2840 cm-1, 1760-1710 cm-1, 1370-1270 cm-1, 
1200-1130 cm-1, 1025-1100 cm-1, and 990-700 cm-1); C) Chained filters: SNV 
transformation, SG-smoothing and first derivative, grey marked regions were excluded 
from PCA. 
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4.4.5 MVA and interpretation  
The application of the preprocessing procedure for the FTIR spectral data previously 
described in Section 4.4.4 achieved distinct clustering in PCA (Figure 7). All treatment groups 
were separated using the first three most significant principal components accounting for 
73% of the variability in the data set. A total of seven components were found to be 
significant (R2X(cum) = 0.94) as assessed by cross validation (Q2X(cum) = 0.91; see Appendix 
8.6 for further model details). Sharp clustering indicates useful reproducibility including 
replication of the instrumental setup. The center-point groups 9, 10 and 11 were included for 
assessing the reproducibility. The sterile broth for group 9, however, was left unfiltered in 
contrast to the broths of all other groups. This deviation may have contributed to separate 
clustering of group 9 on the scores plot PC1 vs PC3 (Figure 7B). The unfiltered broth may 
have contained gel like matrix material. In conclusion, it appears that broth filtration is 
important for the reproducibility. Further, cluster variation of treatment group 6 (5% NaCl, 
pH 6, 39 °C) may be explained by differences in the applied sample films. The bacteria in the 
planktonic culture of group 6 were observed to aggregate, which could have led to variable 
film representations. Furthermore, this observation might suggest an in vivo biofilm forming 
phenotype.  
 
The observation of clear cluster separation led to the conclusion that each combination 
of treatment conditions yielded cultures with a unique and characteristic FTIR profile. Each 
of those profiles may indicate bacterial phenotypic adaptations to cultivation conditions. 
Similar observations were made by Crompton et al. 2014 where treatment conditions led to 
alterations in GC/MS lipid profiles of S. lugdunensis.108  
 
The largest variations in the data set appear to arise from differences in salinity and 
pH - as judged by clustering on scores plot PC1 vs PC2 (Figure 7A). Temperature variations 
in the applied range seemed to have affected the cultures only to a lesser extent as a slight 
trend for the effect of temperature could be assumed along PC6 (Appendix 8.6). These trends 
were further investigated in an OPLS model using salinity, pH, temperature, and OD as 
Y-variables. Predictive components 1 to 3 separated the groups based on salinity, pH, and 
temperature differences in their treatment, respectively. No clustering for OD was obtained 
in any combination of components (see Appendix 8.7 for model details and scores plots). 
These results suggest that salinity contributes most to the differences in the treatment groups, 
closely followed by pH. It also confirmed that the temperature variations affected the 
cultures only to a small extent. 
 
In conclusion, these results suggest that investigating S. aureus phenotypic diversity by 
multivariate data analysis of FTIR spectra obtained from cultures grown under various 
conditions is feasible. Future investigations could include additional conditions to establish a 
global estimate of phenotypic diversity by an analogous approach as that for the ChemGPS 
(Chemical Global Property Screen) initiative.110 The strategy initially aimed to assess growth 
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inhibitory properties of bacteriostatic and bactericidal antibiotics on potential phenotypes. 
However, for exploring the efficacy of anti-virulence agents with this strategy, alternative 
assays would have to be employed. For inhibitors of SrtA, for example, an adherence assay 
under various environmental conditions could be implemented. 
 
 
 
 
 
Figure 7. PCA scores of FTIR spectral data displaying full separation of all treatment 
groups (n = 10, 5 measurements each) using 3 principal components (R2X(cum) = 73%). 
UV scaled, data pretreatment as described in Section 4.4.4. Colorations indicate treatment 
group, numbering refers to treatments in Table 2, and annotations suggest trends. Ellipse: 
95% confidence interval. 
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4.4.6 Impact of factors on the optical density of cultures 
The various conditions of the experimental design affected growth and final optical 
density of the S. aureus cultures (OD590nm 0.44-1.22). MLR was used to examine treatment 
factor relationships and their impact on the OD as response variable. The obtained MLR 
model was significant (R2 = 0.92, Q2 = 0.77), included all factors and the synergistic estimate 
for NaCl*pH. Contour plots as presented in Figure 8 display the condition dependence of 
the OD. Increase in temperature resulted in elevated bacterial growth independent of pH and 
salinity. Low pH and high salinity decreased growth whereas cultures in high pH generally 
yielded higher ODs.  
 
Figure 8. MLR contour plots displaying variations in the optical density of S. aureus 
cultures as a result of different cultivation conditions. Generally, an increased temperature 
and pH led to a higher OD, whereas high salinity and low pH resulted in a decrease of the 
final OD. 
 
4.5 Summary of Paper II 
FTIR spectroscopy was selected for the analyses in this study due to its sensitivity, 
rapidity and potential to analyze live cells. In summary, cultures of S. aureus were grown 
under various environmental conditions according an experimental design. Transmission 
FTIR spectra obtained from each treatment group were preprocessed prior to PCA. The 
applied data preprocessing procedure included SNV transformation, SG smoothing and first 
derivative, and restriction of spectral regions. In a PCA model with UV scaling, all treatment 
groups were fully separated using the first three most significant principal components 
(R2X(cum) = 0.73). Salinity and pH appeared to contribute most to the differences in the 
treatment groups, whereas temperature variations had little effect. These observation are 
sensitive to the applied ranges of conditions. In conclusion, transmission FTIR spectroscopy 
in conjunction with experimental design, and multivariate analysis, presents a powerful tool 
for the investigation of the phenotypic diversity of S. aureus. The limited interpretability of 
resulting FTIR spectra could potentially be complemented by additional analysis methods 
that probe the chemistry specifically. 
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5 MASS SPECTROMETRIC SURFACE ANALYSIS FOR 
BACTERIAL CHARACTERIZATION (PAPER III AND IV)  
 
 
Time-of-flight secondary ion mass spectrometry (ToF-SIMS) was used to further 
characterize bacterial phenotypes. An initial feasibility study included the analysis and 
multivariate differentiation of a set of four bacterial strains. In a subsequent study, changes in 
membrane lipids as a result of adaptation to starvation stress in E. coli were investigated.  
 
5.1 ToF-SIMS 
ToF-SIMS is a highly sensitive surface analysis technique that acquires elemental and 
molecular information through direct analysis of sample surfaces. It allows for the 
interrogation of inorganic, organic and biological surfaces without the requirement for 
derivatization or labeling. By bombarding the sample surface with a high energy primary ion 
beam (usually 10s of keV), analyte species are ejected as secondary ions and subsequently 
analyzed by ToF mass spectrometry. By rastering a fine-focused primary ion beam over a 
sample surface, a mass spectrometric image can be obtained where each pixel represents a 
mass spectrum. These high resolution chemical images can be used to visualize the spatial 
distribution of the chemical constituents in the sample. The analysis can be extended into 
three dimensions by etching the sample surface layerwise to create a 3D chemical image.111  
Due to the small ionization probability, the secondary ion yield is usually very low and 
limits the analysis at submicrometer resolution. Highest yields are obtained from easily 
ionizable molecules such as lipids and small metabolites. The properties of the primary ion 
beam affect the extent of analyte fragmentation and the potential of spatial resolution. 
Atomic ion sources (Cs+, O2+) allow for narrow focus (<50 nm) and yield a high 
fragmentation with little molecular information. The application of cluster (Au3+, Bi3+) and 
polyatomic (SF5+, C60+) ion beams have greatly improved the yield of higher mass intact 
molecular type species.112-115  
Recent advances in the field include the application of gas cluster ion beams (GCIBs) 
which bring considerable benefits especially for the analysis of biological samples.116, 117 
GCIB technology facilitates the generation of higher mass species (m/  up to a few 
thousand) and closes the mass range gap between SIMS and matrix-assisted laser desorption 
ionization (MALDI) mass spectrometry.118 Mass spectrometry imaging with ToF-SIMS has 
become increasingly popular for studying complex biological materials such as cells and 
tissues.118-120 To date, ToF-SIMS has been successfully applied for the analysis of bacterial 
isolates from urinary tract infections,121 bacterial biofilms,122 investigations of Streptomyces 
coelicolor populations123 and for the discrimination of Bacillus strains.124 Furthermore, ToF-
SIMS coupled with tandem MS has been investigated for metabolomics.125  
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5.1.1 J105 3D Chemical Imager 
The J105 ToF-SIMS instrument (Figure 9) implements a new SIMS design and is still subject 
to continuous development. In the J105 instrument, the primary ion beam is operated in a 
quasi-continuous mode, which generates a secondary ion stream that is led into a buncher 
where it is focused into packets of ions. These are then accelerated into a quadratic field 
reflectron mass analyzer and subsequently detected. Ion bunching enables the quasi-
continuous operation of the primary ion source and decouples the mass spectrometry from 
the sputtering process. This eliminates the need for mass calibration for every spectrum and 
allows the analysis of topographically challenging samples with high mass accuracy. Thereby, 
the mass resolution is independent of the spatial resolution which, in principle, enables 
simultaneous acquisition with both resolutions at their best. Furthermore, compared to 
conventional pulsed ion beam SIMS systems, the J105 ToF-SIMS design greatly reduces 
spectral and image acquisition times. The acceleration in the buncher results in an increased 
energy spread (6 keV) of the secondary ions, which necessitates the application of a harmonic 
field ToF reflectron. In there, the ions are separated according to the mass and charge and 
not their energy. The bunching quality is critical as the time focus of secondary ions at the 
entrance of the reflectron affects the mass resolution.126  
 
 
Figure 9. Schematics of the J105–3D Chemical Imager. The secondary ion stream is 
bunched into a focus before entering the harmonic field reflectron ToF analyzer.126 
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The J105 instrument is capable of tandem MS, which is performed in a field free region 
right after the buncher by collision induced dissociation (CID) of the secondary ions with Ar 
gas. Fragment ions and their precursor continue to move with the same velocity and are 
selected using a timed ion gate subsequent to a short ToF region.126  
 
5.2 Bacterial differentiation using ToF-SIMS and MVA (Paper III) 
In an initial study, the potential of using ToF-SIMS in conjunction with MVA for 
bacterial analysis was explored. Primary aims included the optimization of data preprocessing 
for optimal cluster separation in PCA to study small chemical differences that would 
ultimately allow for phenotypic characterization. In order to represent three fineness-levels of 
differences, a set of four bacterial types and strains was used including P. aeruginosa, E. coli, 
and two strains of S. aureus. The largest difference therein was expected to be between the 
Gram-negative and Gram-positive bacteria. The cell envelopes of the Gram-negatives 
themselves may differ on another level and the strains of S. aureus may show only subtle 
differences. With this approach at least three levels of differences were expected to be 
represented in subsequent multivariate modelling. Bacterial samples from each of the four 
strains were obtained after simple washing of cells from an overnight culture in rich medium. 
The samples were applied onto silicon waver and dried prior to ToF-SIMS analysis using a 
C60+ primary ion beam. Resulting mass spectrometric data were investigated with exploratory 
PCA. 
5.2.1 Exploratory PCA of ToF-SIMS data  
Data preprocessing and scaling methods, as described in Section 4.3, were applied to 
optimize clustering in PCA. In addition, data binning was used to mitigate possible peak-shift 
errors that may have arisen from temperature variations during data acquisition. Statistical 
analysis methods like PCA are sensitive to variation of corresponding signals between 
observations, known as the correspondence problem.127 Data binned over 10 data points 
achieved best cluster separation, for the present data set, compared to no binning, or binning 
over 5 or 20 data points. In later studies, data binning was avoided to due to potential 
binning-related artifacts.  
Initially, PCA was used to individually examine data from the positive and negative ion 
modes in order to assess their explanative information and possible redundancy (Figure 10). 
The PCA of positive ion data could discriminate bacterial types but not strains regardless of 
scaling or number of components. The negative ion mode data appeared to contain more 
information for strain differentiation. The largest variation in both data sets appeared to arise 
from characteristic contributions of P. aeruginosa. 
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Figure 10. PCA scores and loadings for examining positive and negative ion mode data 
separately. Pareto scaled PCA with two principal components each; green: E. coli; blue: 
P. aeruginosa; red and yellow: two strains of S. aureus.  
  
Positive ion data 
Negative ion data 
R2: 0.79; Q2: 0.72 
R2: 0.71; Q2: 0.62 
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Combining positive and negative ion mode data resulted in full separation of all test strains 
using the first two or three most significant principal components depending on the scaling 
method (Figure 11). Cluster separation improved with scaling method from no scaling, to 
Pareto, to UV scaling. In contrast, the interpretability of loadings decreased in the same 
order. A PCA with Pareto scaling showed cluster separation and interpretable loadings.  
 
 
 
 
 
 
Figure 11. Comparison between the effects of scaling methods on PCA scores and 
loadings of combined data from positive and negative ion mode spectra. PCA with two 
principal components each; green: E. coli; blue: P. aeruginosa; red and yellow: two strains of 
S. aureus. 
  
UV scaled 
Pareto scaled 
Not scaled negative ions positive ions 
R2: 0.91; Q2: 0.84 
R2: 0.73; Q2: 0.66 
R2: 0.42; Q2: 0.22 
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5.2.2 Elucidation of extra cellular signaling molecule by MSMS 
Collision induced dissociation of m/  272 yielded strong product ions at m/  159 and 
172 (Figure 12). This confirmed that the three largest loading peaks in PC p1 arose from the 
same compound, separating P. aeruginosa from the other strains. Lépine et al. studied 4-
hydroxy-2-alkylquinolines (HAQs) produced by P. aeruginosa and reported m/  272 with its 
fragment ions at m/  172 and 159.128 HAQs have been associated with bacterial virulence 
and are used by P. aeruginosa as extra cellular signaling molecules in quorum sensing (see also 
Section 1.3.2).128 Extra cellular molecules may remain on the surface of the cell samples and 
are thus likely to be detected by ToF-SIMS. 
 
 
 
Figure 12. MSMS Fragment spectrum produced by high energy CID of m/  272 in 
positive ion mode. Putative structures of m/  272 and its fragment ions produced by CID 
of the [M+H]+. 
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5.3 Investigating the role of the stringent response in lipid modifications 
upon starvation in E. coli (Paper IV) 
When E.coli bacteria encounter nutrient limitation, they rapidly adjust their metabolic 
activities in order to promote survival through the starvation period.129, 130 Much of this 
regulation is via the stringent response which further regulates virulence traits and has been 
linked to persistence and drug tolerance.16, 131, 132 The problem of bacterial persistence and 
resistance to antibiotics demands not only the development of new drugs and drug targets, 
but also a better understanding of bacterial physiology in persistence and stress response. In 
this study, changes in membrane lipids as a result of adaptation to starvation stress in E. coli 
were investigated by direct analysis with ToF-SIMS. A mutant strain of E. coli, deficient in the 
stringent response, was included to link observed changes to underlying metabolic pathways. 
5.3.1 The stringent response 
Bacteria have evolved sophisticated stress response mechanisms that allow them to 
adapt to environmental challenges including nutrient limitation and starvation.129, 130 These 
adaptations depend on complex regulatory mechanisms, such as the stringent response, a 
bacterial global gene regulation system. The stringent response is triggered by various 
nutritional stress cues and functions by rapidly reprogramming transcription to adapt 
metabolism and protein composition to ensure survival through the starvation period.133 The 
effector molecule of the stringent response is the unusual nucleotide guanosine 
tetraphosphate (ppGpp). When E. coli bacteria face nutrient starvation, their intracellular 
concentration of ppGpp increases by the synthetic action of the RelA and SpoT enzymes 
(ppGpp synthetases I and II).13, 36, 134 RelA is thought to act specifically in response to amino 
acid limitation, whereas SpoT is activated upon various stress signals, including carbon, 
phosphate, iron and fatty acid starvation.135 As a pleiotropic stress response regulator, ppGpp 
modulates the transcription of hundreds of genes136, 137 and plays a key role, not only in 
starvation survival, but also in biofilm formation, regulation of virulence, drug tolerance, and 
persistence.13, 36, 132, 135 High levels of ppGpp have been linked to increased persister cell 
formation, whereas deficiency in ppGpp production via deletion of the relA and spoT genes 
(coding for ppGpp synthetases I and II, respectively) resulted in much rarer occurrence of 
persister cells in exponentially grown planktonic cultures.20, 22, 138, 139 Finally, ppGpp mediates 
low metabolic activity including slow growth which is associated with persistence and drug 
tolerance and links the stringent response to recalcitrance to antibiotic therapy.16, 22, 131 Due to 
its pivotal role in both persistence and virulence, the stringent response has been investigated 
as potential target for anti-infective therapy.135, 140 
5.3.2 Multivariate data overview 
Cultures of wild-type E. coli K-12 and a ppGpp0 mutant (ΔrelA::kan ΔspoT::cam, 
deficient in production of ppGpp) strain were grown with glucose as limiting substrate and  
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Figure 13. PCA scores and loadings of ToF-SIMS spectral data obtained from wild-type 
E. coli and its ppGpp0 mutant (ΔrelAΔspoT) strain (Pareto-scaled and mean-centered, 
R2 = 0.53; Q2 = 0.50; Ellipse: 95% confidence region). Annotations on the loadings plot 
refer to fatty acids (FA), phosphatidic acids (PA), phosphatidylethanolamines (PE), 
phosphatidylglycerols (PG), cardiolipins (CL). 
 
analyzed with ToF-SIMS in exponential and stationary growth phase. PCA of the mass 
spectral data, shown in Figure 13, was used to examine the data structure. The PCA model 
with Pareto-scaling separated all four different sample types using the first three most 
significant principal components (R2 = 0.53; Q2 = 0.50). The largest variation (PC1) appears 
to arise from growth phase specific lipid differences. The strains in stationary growth phase 
are separated along PC2 due to differences caused by altered lipid modification arising from 
their genetic variation. Finally, the strains in exponential phase share most similarities but 
were distinguished along PC3 based on unassigned differences. Such observations were 
expected as the relA and spoT genes involved in the stringent response are of lesser 
importance in the absence of starvation stress. The differences described by the PCA 
loadings are discussed in further detail in the following sections. 
5.3.3 Mass spectral assignment overview 
Assignment of mass spectral peaks provided insight into the specific differences that 
ultimately allowed one to draw conclusions about the underlying metabolic pathways. 
Assignments include variants of fatty acids (FA), phosphatidic acids (PA), 
phosphatidylethanolamines (PE), phosphatidylglycerols (PG), and cardiolipins (CL), and are 
supported by positive and negative ion mode data, fragmentation patterns, high mass 
accuracy and previously published data.141-152 Further confidence in the assignments is 
provided by logical structural links between assignments as further explained in Figure 14. 
 35 
 
A complete list of assigned molecular species and an example spectrum may be found in the 
appendices (Appendix 8.8 and 8.9). The applied nomenclature e.g. PG(cp35:0) allows direct 
comparison between the different types of phospholipids. The designation within 
parentheses refers to structural features (e.g. cp for cyclopropane), the number of carbons 
within the fatty acyl substituents (e.g. 35), and to the number of unsaturations within the acyl 
chains (e.g. 0).  
 
 
 
Figure 14. Fragmentation during ion generation gives rise to a structural relationship 
between observed ions. This increases confidence in assignments of structural analogues 
and the exclusion of unrelated structures with isobaric interference. The schematic shows 
possible fragmentation yielding classes of smaller ions e.g. by the loss of the head group. 
As a consequence of fragmentation, it is uncertain which or how much of the species are 
actually present in the sample. Structures are shown as examples, whereby the 
conformational kink introduced by cp is not illustrated. 
 
5.3.4 Membrane lipid composition in exponential growth phase.  
Both, wild-type E. coli and the ppGpp0 mutant in exponential phase were found to 
primarily have saturated fatty acids and phospholipids incorporated in their membranes. 
Mass spectral assignments identified the fatty acids FA(16:0), FA(14:0), FA(12:0) and 
FA(10:0), as well as the phospholipids PG(28:0) and PG(26:0), including their PE and PA 
analogues. The evenly numbered acyl chains can be explained by the mechanism of fatty acid 
synthesis which applies two-carbon building blocks in an iterative process.153, 154 Interestingly, 
these saturated phospholipids appear to have a complete set of hydroxylated analogues. 
However, only the hydroxy fatty acids FA(OH-10:0) and FA(OH-12:0) were detected. Signals 
corresponding to FA(OH-14:0) and FA(OH-16:0) fatty acids were not observed. Therefore, 
it remains unclear whether hydroxy phospholipids are an artifact of our analysis procedure or 
could be detected due to analyzing native samples. The assignment of hydroxy phospholipids 
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is tentative, nevertheless, most assignments from exponential growth are consistent in their 
structural relationship and are supported by previous studies.145, 149, 150, 152 
5.3.5 Membrane lipid composition in stationary growth phase of wild-type E. coli.  
The lipid composition of E. coli in stationary phase was found to be radically different 
as compared to exponentially grown cells. The starved cells appeared to have modified their 
membrane lipids by elongation and cyclopropanation of their pre-existing153 fatty acyl chains. 
As a result, the majority of dominant peaks were attributable to cyclopropane containing 
species of FA, PA, PE, PG, and CL. Cyclopropane containing lipids have previously been 
described as physiologically useful as they confer increased resistance to environmental 
insults such as acid stress.155 Further, the cp ring affects the confirmation of the acyl chain by 
the introduction of a kink, resulting in less dense lipid packing and in turn, in an increase in 
the membrane’s fluidity.153 The cp containing fatty acids FA(cp17:0) and FA(cp19:0) gave 
rise to the most intense peaks in the negative ion mode mass spectrum. Due to their high 
abundance, their positive ion counter parts were tentatively assigned to the unusual positive 
ions [FA+26]+ (Appendix 8.10). Further peaks consistent with fatty acids were assigned to 
FA(14:0), FA(16:1), FA(16:0), and FA(18:1). The largest peaks attributable to phospholipids 
were assigned to PG(cp33:0), PG(cp35:0) and their PE and PA analogues. CL levels 
increased strongly during stationary phase, whereby only cp containing CL species were 
observed. CL can be formed by condensation of two PGs, or PG and PE by CL synthase 
(Cls)156, 157 The activity of Cls has been reported to increase 10-fold when entering stationary 
phase, which supports our observation.158 Further, CL are crucial for viability in long-term 
stationary phase.156 
The time point in the growth curve in which a planktonic culture of E. coli is sampled is 
critical to the types of lipids that can be detected, and should to be considered when 
sampling any type of bacterium. The modification of phospholipids appeared to progress, 
even during the stationary phase itself, as found serendipitously. In early stationary phase, 
phospholipids exhibiting one cp ring were observed, and as cyclopropanation continued, 
species with two cp rings began to appear (as illustrated in Figure 15A and B). This time 
dependent appearance suggests that existing phospholipids are modified.153 
 
 
Figure 15A. Ratios of doubly to singly cyclopropanated PG and PE in wild-type E. coli 
over time in the stationary phase. Error bars show standard deviation (n = 6). 
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Figure 15B. ToF-SIMS spectra to illustrate the time-dependent lipid modification in 
stationary phase of wild-type E. coli. First, phospholipids with a single cp ring are detected 
and as cyclopropanation progresses also species with two cp rings appear. The example 
structure is consistent with m/  733. Spectra are normalized based on noise levels. 
 
5.3.6 Anomalies in the phospholipid modifications of ppGpp0 mutant E. coli in 
stationary phase.  
The lipid profile of the ppGpp0 mutant in exponential growth phase was very similar to 
that of the wild-type. This was expected as ppGpp is not synthesized significantly during 
exponential growth and, therefore, lack of the genes coding for ppGpp synthases would not 
affect homeostasis noticeably. In stationary phase, however, wild-type E. coli elicits the 
stringent response by expression of relA and/or spoT leading to production of ppGpp. 
Resulting phospholipid modifications yielded cp containing lipids which were observed 
exclusively in wild-type cells. Interestingly, the ppGpp0 mutant in stationary phase was found 
to have a complete set of unsaturated analogues of these cp lipids instead (Figure 16). The 
observed ions are consistent with PG(34:1), PG(32:1), PE(34:1), PE(32:1), PA(34:1), 
PA(32:1), FA(18:1), and FA(16:1). This was somewhat unexpected as the relaxed response 
yields a proteomic profile159 as well as a gene expression profile160 in stationary phase similar 
to that during growth.13 Like the wild-type, the ppGpp0 mutant responds to starvation stress 
with elongation and desaturation of pre-existing fatty acyl chains. However, in the wild-type, 
ppGpp stimulates accumulation of the RpoS regulon which controls the cfa gene encoding 
cyclopropane fatty acid synthase (Cfa). Cfa is required for the subsequent methylation of the 
double bond to form cyclopropane moieties.153 Deletion of the genes encoding RelA and 
SpoT renders the mutant strain deficient in production of ppGpp which leads to an altered  
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Figure 16. Lipid modifications in the stationary growth phase of wild-type E. coli and its 
ppGpp0 mutant strain include elongation and desaturation of preexisting phospholipids, 
however, only the wild-type is capable of subsequent cyclopropanation by Cfa. As a result, 
the mutant cells exhibited unsaturated analogues (red spectrum, negative ion mode) of the 
cp phospholipids found in the wild-type (blue spectrum). The mechanism that introduces 
the unsaturations is currently unclear. Structures are shown as an example; modifications 
can occur in Δ5 or Δ9 positions. The conformational kink introduced by the modifications 
is not illustrated.153 
 
stress response and incomplete phospholipid modification. The observation of unsaturated 
analogues suggests that only the last step of the modifications, the cyclopropanation, is under 
ppGpp control. Further, this may indicate alternative stress response mechanisms, which 
regulate the membrane lipid structure independently from ppGpp. 
It is currently unclear how the observed desaturation occurs in E. coli. Other types of 
bacteria use desaturases to modify their pre-existing phospholipids.134 However, wild-type 
E. coli does not produce desaturases and has therefore been used to recombinantly express 
desaturases.161 In E. coli, FabA and FabB are enzymes involved in the formation of double 
bonds. These enzymes are known to process acyl carrier protein (ACP) linked acyls during de 
novo biosynthesis of fatty acids.134, 153 The data from this study suggest, however, that the 
modification occurs on pre-existing phospholipids rather than by de novo synthesis. Also the 
transcriptional regulation of the fabA and fabB genes indicates that the desaturation occurs by 
another mechanism. The fabA gene is repressed in starvation162, 163 and fabB is shown to be 
downregulated during amino acid starvation164 while induced in the stationary phase in LB 
medium.162 While the underlying mechanism of the observed unsaturations is poorly 
understood, our results suggest that the biosynthesis of the enzyme(s) involved in 
desaturation is not regulated by ppGpp. 
The absence of signals corresponding to unsaturated CL analogues in the ppGpp0 
mutant cells might suggest that Cls activity is ppGpp dependent. This, however, remains 
speculative and could also be due to low intensity. 
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5.3.7 Implications of lipid structure alterations in cell morphology and membrane 
homeostasis 
The molecular alterations of the lipid structure, described above, may contribute to the 
morphological differences between the cells observed in brightfield microscopy (Figure 17). 
The similar lipid profiles of the wild-type and the ppGpp0 mutant in exponential growth 
phase were accompanied by a close resemblance in the appearance of their rod-shaped cells 
(Figure 17A and B, respectively). In the stationary phase, wild-type E. coli appears to make 
further restrictions to form small, almost spherical cells that segregate in to a large number of 
cells — a strategy which may increase the chance of survival (Figure 17C). Thereby, the high 
curvature of the cells may be allowed by the increased CL content in their membranes. 
Previously, CL domains have been associated with regions of high cell curvature and have 
been localized to the cell poles as well as at division sites.157 The significant increase in cp 
lipid species may further contribute to the curved shape, which is speculative and remains to 
be investigated. The ppGpp0 mutant fails to become coccoid in stationary phase and forms  
 
 
Figure 17. Brightfield microscopy images of E. coli wild-type and its ppGpp0 mutant 
(ΔrelAΔspoT) strain in mid-exponential growth phase (A and B, respectively), and during 
stationary phase (C and D, respectively). The images were captured slightly defocused to 
enhance contrast, using a Zeiss Axiovert 200M inverted microscope equipped with a 100× 
plan apochromat (NA 1.4) oil immersion objective. 
A B 
C D 
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filaments and pear-shaped cells instead (Figure 17D).165 The lipid structures might contribute 
to a certain part to the odd cell shapes, however, deletion of a global gene regulation system, 
such as the stringent response, may have far reaching implications. 
It has previously been established that the structural integrity and function of 
membrane proteins are affected by their lipid environments.157, 166 The growth condition 
dependent lipid composition may, therefore, affect the binding affinity of drug molecules to 
membrane proteins.166 Moreover, the membrane permeability may change based on its 
composition, which might affect the target engagement of antibiotics and thereby further 
complicate the search for new drug-like molecules that effectively penetrate the bacterial 
barrier. A comprehensive understanding of compound penetration in bacteria to guide the 
development of synthetic antimicrobials still remains to be established.167 
It has been shown that environmental parameters affect the membrane fatty acid 
composition and also the sensitivity to Gentamycin of Staphylococcus lugdunensis.108 The role of 
lipids in modulating protein function has yet to be fully understood. 
 
5.4 Summary of Paper III and IV 
ToF-SIMS in conjunction with MVA was applied for direct and untargeted analysis of 
various bacterial types and strains. In an initial study, a set of four bacteria was distinguished 
down to the strain level. MSMS data provided information that allowed the identification of 
an extra cellular signaling molecule of P. aeruginosa. In a subsequent study, membrane lipid 
modifications as a result of adaptation to starvation stress in E. coli were investigated and 
compared to a ppGpp0 mutant strain, deficient in the stringent response. The two strains 
shared strong similarities in exponential growth phase, regarding ToF-SIMS spectra, lipid 
composition and cell morphology. In stationary phase, the cells appeared to have undergone 
radical changes in the lipid structure, resulting in the wild-type in cyclopropanated lipids and 
largely increased CL levels. In contrast, the ppGpp0 mutant cells were found to exhibit 
unsaturated analogues of lipids found in the wild-type. This indicates that only the last step of 
the lipid modification, the cyclopropanation, is under stringent control and further suggests 
ppGpp independent stress response mechanisms. 
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6 CONCLUDING REMARKS AND FUTURE PERSPECTIVES  
 
 
This thesis describes firstly the discovery, synthesis and evaluation of inhibitors of SrtA, 
and secondly the phenotypic characterization of bacteria using FTIR spectroscopy and ToF-
SIMS. FTIR spectroscopy in combination with DOE and MVA was found to be a powerful 
tool for the investigation of phenotypic diversity of S. aureus. ToF-SIMS in conjunction with 
MVA was shown to be capable of differentiating a number of bacterial strains. Further 
investigations with ToF-SIMS included starvation experiments, which revealed ppGpp 
independent lipid modifications in E. coli. 
 
Further studies that would be of interest include: 
 
 
 The impact of ToF-SIMS surface sampling on bacterial cells is currently unclear. 
Scanning electron microscopy may be applied to gain insight in sample surface 
alterations of primary ion beam(s). Furthermore, it may be attempted to resolve 
differences between the inner and the outer membranes of Gram-negative bacteria by 
3D chemical imaging. 
 
 ToF-SIMS may be applied for the investigation of small colony variants (SCV), which 
due to the low amount of sample are challenging to analyze with other methods. 
 
 ToF-SIMS maybe applied to further investigate lipid modifications of E. coli mutants 
(e.g. cfa deletion, hipA overexpression) to gain insight in persister cell physiology. 
 
 CFA phospholipids may contribute to cell curvature. It could be of interest to localize 
CFA lipids to curved regions (poles) of exponentially growing E. coli using Nano-
SIMS. 
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8 APPENDICES 
 
8.1 Appendix 1.  
 
 
8.2 Appendix 2.  
 
 
8.3 Appendix 3.  
 
 
8.4 Appendix 4. FTIR instrumental setup 
 
 
 
Figure A1. FTIR spectrometer with custom built xy-stage holding a ZnSe well plate as it 
was used to acquire FTIR spectra of bacterial samples.  
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8.5 Appendix 5. FTIR optical substrate comparison 
 
 
Figure A2. Solid line spectra show replicate measurements of blank Polyethylene (M3) as 
optical windows, dashed spectra show a bacterial spectrum for relative comparison.  
 
Figure A3. Solid line spectra show replicate measurements of blank Silicon waver as 
optical windows, dashed spectra show a bacterial spectrum for relative comparison.  
 
 
Figure A4. Solid line spectra show replicate measurements of blank individual ZnSe 
windows as optical windows, dashed spectra show a bacterial spectrum for relative 
comparison.  
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Figure A5. Solid line spectra show replicate measurements of blank ZnSe well plate 
optical windows, dashed spectra show a bacterial spectrum for relative comparison.  
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8.6 Appendix 6. PCA scores plot PC6 vs PC3 
 
 
Figure A6. PCA scores plot PC6 vs PC3. Slight separation of high temparature samples 
could be assumed along PC6. UV scaled; red: high temperature; green: intermediate 
temperature; blue: low temperature. 
 
 
Table A1. PCA model details 
Component  R2X  R2X(cum)  Eigenvalue   Q2   Q2(cum)  Significance  
0  Cent.  
 
  
 
 
  
1  0.43  0.43  25.8   0.418   0.418  R1  
2  0.169  0.599  10.2   0.261   0.57  R1  
3  0.13  0.729  7.78   0.306   0.702  R1  
4  0.0806  0.81  4.84   0.25   0.776  R1  
5  0.0498  0.86  2.99   0.191   0.819  R1  
6  0.0459  0.905  2.75   0.304   0.874  R1  
7  0.0301  0.936  1.81   0.282   0.909  R1  
8  0.0172  0.953  1.03   0.233   0.931  R1  
9  0.0113  0.964  0.679   0.175   0.943  R1  
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8.7 Appendix 7. OPLS model 
Table A2. OPLS model details 
Component  R2X  R2X(cum)  Eigenvalue  R2  R2(cum)  Q2  Q2(cum)  R2Y  R2Y(cum)  EigenvalueY  Significance  
Model  
 
0.955  
  
0.947  
 
0.908  
 
1  
  
  
           
Predictive  
 
0.575  
  
0.947  
 
0.908  
 
1  
  
P1  0.326  0.326  19.5  0.274  0.274  0.201  0.201  0.282  0.282  1.41  R1  
P2  0.153  0.478  9.15  0.335  0.609  0.302  0.503  0.341  0.623  1.71  R1  
P3  0.0447  0.523  2.68  0.203  0.812  0.225  0.727  0.225  0.848  1.13  R1  
P4  0.0403  0.563  2.42  0.0855  0.898  0.129  0.856  0.0949  0.943  0.474  R1  
P5  0.0116  0.575  0.696  0.0493  0.947  0.0519  0.908  0.057  1  0.285  R1  
  
           
Orthogonal 
in X(OPLS)   
0.38  
  
0  
      
O1  0.17  0.17  10.2  0  0  
     
R1  
O2  0.072  0.242  4.32  0  0  
     
R1  
O3  0.0752  0.317  4.51  0  0  
     
R1  
O4  0.0365  0.353  2.19  0  0  
     
R1  
O5  0.0264  0.38  1.59  0  0  
     
R1  
 
 
 
Figure A7. OPLS scores plot pc1 vs pc2. Blue: low salinity; Red: high salinity; Green: 
intermediate salinity. 
 
 
  
 49 
 
 
 
Figure A8. OPLS scores plot pc1 vs pc2. Blue: low pH; Red: high pH; Green: 
intermediate pH. 
 
 
 
 
Figure A9. OPLS scores plot pc1 vs pc3. Blue: low temperature; Red: high temperature; 
Green: intermediate temperature. 
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8.8 Appendix 8. ToF-SIMS spectral assignments 
Table A3. Assignments of signals observed in ToF-SIMS spectra of wild-type and 
ppGpp0 mutant E. coli in exponential and stationary growth phase.  
 
 
Negative ion mode 
 
Positive ion mode 
Assignment 
meas. m/  
[M-H]-  
Ion formula 
 
meas. m/  Species Ion formula 
   
 
  
 Head groups and fragments 
 
 
  
 
 
78.9 PO3- 
 
- - - 
Dihydrogenphosphate 96.9695 H2PO4- 
 
- - - 
 
134.9848 C3H4O4P- 
 
- - - 
 
137.0029 C3H6O4P- 
 
- - - 
Phosphoethanolamine 140.0136 C2H7NO4P- 
 
- - - 
 
152.9975 C3H6O5P- 
 
- - - 
 
158.926 HP2O6- 
 
- - - 
Phosphoglycerol 171.0076 C3H8O6P- 
 
- - - 
Pyrophosphate 176.9394 H3P2O7- 
 
- - - 
 
196.0387 
C3H5OPO4CH2
CH2NH2-  
- - - 
   
 
  
 Fatty acids 
  
 
  
 FA (10:0) 171.1084 C10H19O2- 
 
- - - 
FA (OH-10:0) 187.1 C10H19O3- 
 
- - - 
FA (12:1) 197.1194 C12H21O2- 
 
- - - 
FA (12:0) 199.1348 C12H23O2- 
 
- - - 
FA (OH-12:0) 215.1294 C12H23O3- 
 
- - - 
FA (14:0) 227.2005 C14H27O2- 
 
- - - 
FA (16:1) 253.2154 C16H29O2- 
 
- - - 
FA (16:0) 255.2323 C16H31O2- 
 
282.2559 [FA+26]+ C18H34O2•+ 
FA (cp17:0)  267.2328 C17H31O2- 
 
294.2561 [FA+26]+ C19H34O2•+ 
FA (18:1) 281.2476 C18H33O2- 
 
308.2746 [FA+26]+ C20H36O2•+ 
FA (cp19:0) 295.2640 C19H35O2- 
 
322.2894 [FA+26]+ C21H38O2•+ 
       
Phosphatidic acids 
      
PA (26:0) 563.3406 C29H56O8P- 
 
467.4019 [M+H-98]+ C29H55O4+ 
PA (OH-26:0) 579.3196 C29H56O9P- 
 
483.3837 [M+H-98]+ C29H55O5+ 
PA (28:0)  591.3553 C31H60O8P- 
 
495.4194 [M+H-98]+ C31H59O4+ 
PA (OH-28:0) 606.37 C31H59O9P- 
 
- - - 
PA (30:0) 619.4033 C33H64O8P- 
 
523.4854 [M+H-98]+ C33H63O4+ 
PA (OH-30:0) 635.3829 C33H64O9P- 
 
- - - 
PA (32:1) 645.4574 C35H66O8P- 
 
549.5043 [M+H-98]+ C35H65O4+ 
PA (cp33:0) 659.467 C36H68O8P- 
 
563.5035 [M+H-98]+ C36H67O4+ 
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PA (34:2) - - 
 
575.5015 [M+H-98]+ C37H67O4+ 
PA (34:1) 673.4778 C37H70O8P- 
 
577.5194 [M+H-98]+ C37H69O4+ 
PA (cp35:0) 687.4995 C38H72O8P- 
 
591.5370 [M+H-98]+ C38H71O4+ 
PA (cp36:0) 699.4932 C39H72O8P- 
 
603.5366 [M+H-98]+ C39H71O4+ 
PA (cp38:0) 727.5284 C41H76O8P- 
 
631.5678 [M+H-98]+ C41H75O4+ 
   
 
  
 Phosphatidylethanolamines 
     
PE (26:0) 606.37 C31H61NO8P- 
 
467.3890 [M+H-141]+ C29H55O4+ 
PE (OH-26:0) 622.3666 C31H61NO9P- 
 
483.3837 [M+H-141]+ C29H55O5+ 
PE (28:0) 634.3988 C33H65NO8P- 
 
495.4194 [M+H-141]+ C31H59O4+ 
PE (OH-28:0) 650.3968 C33H65NO9P- 
 
652.4215 [M+H]+ C33H67NO9P+ 
    
511.4145 [M+H-141]+ C31H59O5+ 
PE (30:0) 662.4624 C35H69NO8P- 
 
664.4884 [M+H]+ C35H71NO8P+ 
    
523.4854 [M+H-141]+ C33H63O4+ 
PE (OH-30:0) 678.4913 C35H69NO9P- 
 
- - - 
PE (32:1);  688.4936 C37H71NO8P- 
 
690.5148 [M+H]+ C37H73NO8P+ 
PE (cp33:0) 702.5097 C38H73NO8P- 
 
704.5321 [M+H]+ C38H75NO8P+ 
    
563.5035 [M+H-141]+ C36H67O4+ 
    
742.4944 [M+K]+ C38H74KNO8P+ 
PE (34:2) 714.5061 C39H73NO8P- 
 
716.5088 [M+H]+ C39H75NO8P+ 
PE (cp34:0) 714.5061 C39H73NO8P- 
 
716.5088 [M+H]+ C39H75NO8P+ 
PE (34:1) 716.524 C39H75NO8P- 
 
718.5441 [M+H]+ C39H77NO8P+ 
    
577.5194 [M+H-141]+ C37H69O4+ 
PE (cp35:0) 730.5421 C40H77NO8P- 
 
591.5370 [M+H-141]+ C38H71O4+ 
    
770.5214 [M+K]+ C40H78KNO8P+ 
PE (36:2) 742.5395 C41H77NO8P- 
 
603.5366 [M+H-141]+ C39H71O4+ 
PE (cp36:0) 742.5395 C41H77NO8P- 
 
603.5366 [M+H-141]+ C39H71O4+ 
PE (cp38:0) 770.5683 C43H81NO8P- 
 
631.5678 [M+H-141]+ C41H75O4+ 
       
Phosphatidylglycerols 
     
PG (26:1) 635.3829 C32H60O10P- 
 
465.3890 [M+H-172]+ C29H53O4+ 
PG (26:0) 637.3713 C32H62O10P- 
 
467.3890 [M+H-172]+ C29H55O4+ 
PG (OH-26:0) 653.3404 C32H62O11P- 
 
483.3837 [M+H-172]+ C29H55O5+ 
PG (28:0) 665.4012 C34H66O10P- 
 
495.4194 [M+H-172]+ C31H59O4+ 
PG (OH-28:0) 681.3929 C34H66O11P- 
 
511.4145 [M+H-172]+ C31H59O5+ 
PG (30:0) 693.4567 C36H70O10P- 
 
523.4854 [M+H-172]+ C33H63O4+ 
PG (OH-30:0) 709.4159 C36H70O11P- 
 
- - - 
PG (32:1) 719.4913 C38H72O10P- 
 
549.5043 [M+H-172]+ C35H65O4+ 
PG (32:0) 721.4998 C38H74O10P- 
 
551.5003 [M+H-172]+ C35H67O4+ 
PG (cp33:0) 733.5066 C39H74O10P- 
 
563.5035 [M+H-172]+ C36H67O4+ 
PG (34:2) 745.5059 C40H74O10P- 
 
575.5015 [M+H-172]+ C37H67O4+ 
PG (cp34:0) 745.5059 C40H74O10P- 
 
575.5015 [M+H-172]+ C37H67O4+ 
PG (34:1) 747.5205 C40H76O10P- 
 
577.5194 [M+H-172]+ C37H69O4+ 
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PG (cp35:0) 761.5337 C41H78O10P- 
 
591.5370 [M+H-172]+ C38H71O4+ 
PG (36:2) 773.5336 C42H78O10P- 
 
603.5366 [M+H-172]+ C39H71O4+ 
PG (cp36:0) 773.5336 C42H78O10P- 
 
603.5366 [M+H-172]+ C39H71O4+ 
PG (cp38:0) 801.5586 C44H82O10P- 
 
631.5678 [M+H-172]+ C41H75O4+ 
       
Cardiolipins 
      
CL (cp65:0) 1363.9178 C74H141O17P2- 
 
- - - 
CL (cp66:0) 1375.9391 C75H141O17P2- 
 
- - - 
CL (cp67:1) 1389.9347 C76H143O17P2- 
 
- - - 
CL (cp68:1) 1401.9524 C77H143O17P2- 
 
- - - 
CL (cp86:0) 1404.0054 C77H145O17P2- 
 
- - - 
CL (cp69:0) 1416.0159 C78H145O17P2- 
 
- - - 
CL (cp69:1) 1417.991 C78H147O17P2- 
 
- - - 
CL (cp70:1) 1429.9609 C79H147O17P2- 
 
- - - 
CL (cp70:0) 1432.0219 C79H149O17P2- 
 
- - - 
CL (cp72:1); CL (71:0) 1444.0205 C80H149O17P2- 
 
- - - 
CL (cp73:0) 1473.0373 C82H154O17P2- 
 
- - - 
CL (cp74:0) 1484.032 C83H153O17P2- 
 
- - - 
 
 
8.9 Appendix 9. ToF-SIMS example spectrum 
 
Figure A10. Typical ToF-SIMS spectrum in negative ion mode obtained from wildtype 
E. coli in stationary growth phase. 
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8.10 Appendix 10. Phospholipid Fragmentation in ToF-SIMS  
 
 
Figure A11. Characteristic abundances of the fatty acids FA(cp17:0) and FA(cp19:0), as 
assigned via negative ion mode data, allowed their assignments also in positive ion mode 
to [FA+26]+ ions. Fragmentation processes of phospholipids as suggested by Hsu and 
Turk145 result in a loss of the head group ((OH)2POOX) with product ions ([M+H-
(OH)2POOX]+) that were observed also in here, see also Table 1. Further fragmentation 
of these ions may result in the formation of [FA+26]+ species. 
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